Published on
August 5, 2021
- 11:48 GMT
Altoida's Precision Neurology Device Wins FDA Breakthrough Designation for Prediction of Alzheimer's Disease with AI
Breakthrough Designation will advance the development of industry’s first predictive diagnostic device for conversion to Alzheimer’s disease. WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, August 5, 2021 /EINPresswire.com/ -- Altoida, Inc., a pioneer …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Science
...
